PEBP1P3

Across TCGA pan-cancer cohorts, PEBP1P3 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated PEBP1P3 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher PEBP1P3 RNA is associated with better overall survival. In most high-consensus cancer types, elevated PEBP1P3 expression acts as an unfavorable survival marker, although some lineages such as UCS and BLCA show a favorable association.

UCS, BLCA, and KIRC are the cancer types where PEBP1P3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	II,III,IV	0.845	0.283	.005	108	view →
BLCA	OS	Median	III,IV	0.494	0.260	.002	56	view →
KIRC	OS	Tertile	All	0.495	0.695	<.001	53	view →
HNSC	OS	Quartile	All	0.506	0.324	.001	48	view →
LGG	DFS	Tertile	All	0.235	0.440	<.001	30	view →
SKCM	OS	Tertile	All	0.840	0.740	.004	23	view →
COAD	OS	Tertile	III,IV	0.663	0.830	.007	18	view →
ESCA	DFS	Median	III,IV	0.428	0.232	.013	12	view →
LAML	DFS	Tertile	All	0.366	0.710	.003	12	view →
CESC	DFS	Median	All	0.637	0.461	.016	10	view →
LUAD	OS	Quartile	All	0.820	0.650	.015	10	view →
THCA	DFS	Median	All	0.966	0.877	.011	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

PEBP1P3–UCS (OS)

Open the UCS breakdown →